drugset / Trial / NCT01045863
To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers
RandomizedCrossoverDouble-blind
Summary
The purpose of this study is to evaluate safety and tolerability after a single administration of PF-03382792 in healthy volunteers.; and to evaluate plasma drug levels and biological activity.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-06
- Completion
- 2010-06
Outcome
Outcome not reported
Stopped: “See termination reason in detailed description.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03382792 | Small molecule | 0.05 mg | Oral |
| Subject | PF-03382792 | Small molecule | 0.15 mg | Oral |
| Subject | PF-03382792 | Small molecule | 0.5 mg | Oral |
Indications
No indication recorded.